Kayne Anderson Rudnick Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.8K Sell
220
-15
-6% -$1.34K ﹤0.01% 650
2025
Q4
$18.6K Hold
235
﹤0.01% 671
2025
Q3
$18.8K Sell
235
-28
-11% -$2.39K ﹤0.01% 678
2025
Q2
$23.9K Sell
263
-15
-5% -$1.37K ﹤0.01% 661
2025
Q1
$26K Sell
278
-27
-9% -$2.42K ﹤0.01% 631
2024
Q4
$27.7K Sell
305
-16
-5% -$1.53K ﹤0.01% 601
2024
Q3
$33.3K Sell
321
-39
-11% -$3.98K ﹤0.01% 579
2024
Q2
$34.9K Sell
360
-10
-3% -$922 ﹤0.01% 558
2024
Q1
$33.3K Sell
370
-24
-6% -$2.03K ﹤0.01% 564
2023
Q4
$31.4K Sell
394
-102
-21% -$7.67K ﹤0.01% 550
2023
Q3
$35.3K Buy
496
+291
+142% +$21.8K ﹤0.01% 528
2023
Q2
$15.8K Buy
205
+5
+3% +$387 ﹤0.01% 572
2023
Q1
$15K Hold
200
﹤0.01% 552
2022
Q4
$15.8K Hold
200
﹤0.01% 564
2022
Q3
$14K Hold
200
﹤0.01% 545
2022
Q2
$16K Hold
200
﹤0.01% 526
2022
Q1
$15K Hold
200
﹤0.01% 515
2021
Q4
$17K Buy
+200
New +$15.6K ﹤0.01% 519
2020
Q1
Sell
-29
Closed -$2K 622
2019
Q4
$2K Buy
+29
New +$1.98K ﹤0.01% 557
2017
Q1
Sell
-201,440
Closed -$13.2M 335
2016
Q4
$13.2M Sell
201,440
-6,622
-3% -$454K 0.16% 148
2016
Q3
$15.4M Buy
208,062
+60,600
+41% +$4.48M 0.19% 145
2016
Q2
$10.8M Sell
147,462
-59,027
-29% -$4.2M 0.16% 143
2016
Q1
$14.6M Sell
206,489
-4,029
-2% -$268K 0.24% 120
2015
Q4
$14M Sell
210,518
-3,155
-1% -$210K 0.23% 118
2015
Q3
$13.6M Sell
213,673
-4,060
-2% -$265K 0.23% 112
2015
Q2
$14.2M Sell
217,733
-3,548
-2% -$241K 0.22% 125
2015
Q1
$15.3M Sell
221,281
-4,345
-2% -$300K 0.24% 116
2014
Q4
$15.6M Sell
225,626
-116,613
-34% -$7.88M 0.26% 105
2014
Q3
$22.3M Sell
342,239
-7,969
-2% -$526K 0.4% 77
2014
Q2
$23.9M Sell
350,208
-3,935
-1% -$264K 0.41% 66
2014
Q1
$23M Sell
354,143
-6,470
-2% -$408K 0.4% 69
2013
Q4
$23.5M Sell
360,613
-5,754
-2% -$368K 0.39% 68
2013
Q3
$21.7M Sell
366,367
-5,229
-1% -$310K 0.41% 66
2013
Q2
$21.3M Buy
+371,596
New +$22.1M 0.43% 64

Other funds holding CL

Kayne Anderson Rudnick Investment Management's CL Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its Colgate-Palmolive (CL) stake by 6.4% in Q1 2026, selling an estimated $1.34K and leaving 220 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #650.

Kayne Anderson Rudnick Investment Management first reported a position in CL in Q2 2013 and has held it in 34 quarters since. The position peaked at $23.9M in Q2 2014. 1,953 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management held 220 shares of Colgate-Palmolive worth $18.8K as of Q1 2026.
  • Kayne Anderson Rudnick Investment Management sold 15 Colgate-Palmolive shares in Q1 2026, an estimated $1.34K.
  • Colgate-Palmolive made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #650 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 34 quarters since.
  • Kayne Anderson Rudnick Investment Management's Colgate-Palmolive position peaked at $23.9M in Q2 2014.
  • 1,953 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.